Bi-specific antibodies are engineered proteins that can bind two different types of antigens simultaneously. Unlike traditional monoclonal antibodies, which target a single antigen, bi-specific antibodies are designed to recognize and attach to two distinct targets. This unique capability allows them to bring together two different cells, such as a cancer cell and an immune cell, to enhance the immune response against cancer.
